SMTL ID : 6ed6.2 (1 other biounit)

Crystal structure of Rock2 with a pyridinylbenzamide based inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.86 Å

Oligo State

monomer

Ligands

1 x J0P: N-[(2,3-dihydro-1,4-benzodioxin-5-yl)methyl]-4-(pyridin-4-yl)benzamide(Non-covalent)

J0P.1: 20 residues within 4Å: Chain A: I.96, R.98, G.99, F.101, G.102, E.103, V.104, A.117, K.119, L.121, F.134, E.138, M.167, E.168, Y.169, M.170, L.219, A.229, D.230, F.382 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:I.96, A:V.104, A:V.104, A:A.117, A:L.121, A:L.219, A:A.229 Hydrogen bonds: A:F.101, A:K.119, A:M.170

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hobson, A.D. et al., Identification of Selective Dual ROCK1 and ROCK2 Inhibitors Using Structure Based Drug Design. J. Med. Chem. (2018)

Release Date

2018-11-14

Peptides

Rho-associated protein kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Rho-associated protein kinase 2

Related Entries With Identical Sequence